Lucknow, India

Ashan Manhas

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2019.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ashan Manhas: Innovator in Anti-Malarial Compounds

Introduction

Ashan Manhas is a notable inventor based in Lucknow, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-malarial compounds. His work is crucial in the ongoing fight against malaria, a disease that continues to affect millions worldwide.

Latest Patents

Ashan Manhas holds a patent for "Aromatic derivatives as anti-malarial." This invention discloses an anti-malarial compound of formula (I), where X is selected from O or NH. The components R, R, R, R, and R are selected from H, OMe, or various alkyl groups. The patent also includes a process for preparation and a pharmaceutical composition containing the compound. He has 1 patent to his name, showcasing his innovative approach to combating malaria.

Career Highlights

Ashan Manhas is affiliated with the Council of Scientific and Industrial Research, where he conducts research and development in the field of pharmaceuticals. His work has been instrumental in advancing the understanding of anti-malarial compounds and their applications.

Collaborations

He collaborates with esteemed colleagues such as Asish Kumar Bhattacharya and Eswar Kumar Aratikatla. Their combined expertise enhances the research efforts at the Council of Scientific and Industrial Research.

Conclusion

Ashan Manhas is a dedicated inventor whose work in anti-malarial compounds is making a significant impact in the field of medicine. His contributions are vital in the fight against malaria, and his innovative spirit continues to inspire future research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…